Synthetic peptide immunotherapeutic: Expanded Phase I trials to evaluate the levels of cytotoxic T cell (CTL) activity directed against HIV, and to monitor the

United Biomedical Inc., Hauppauge, N.Y. Product: Synthetic peptide immunotherapeutic Indication: HIV infection Status: Expanded Phase I trials to evaluate the levels of cytotoxic T cell (CTL) activity...